VacciniaSTATUVAX-PRONCT06650722
Evaluation of Healthcare Workers Knowledge Regarding Their Vaccination Status at Melun Hospital
An observational study of Vaccinia, run by Groupe Hospitalier Sud Ile-de-France at 1 site in France.
Trial summary
The goal of this observational study is to learn about the rate the of knowledge of own vaccination status among healthcare workers working at Groupe Hospitalier Sud Ile de France. Read more about this study
- Who is it for?
- Any ageHealthy volunteers can take part
- Conditions the study is for
- Vaccinia
- How many people
- 100 participants
- Where
- 1 siteFrance
- Study dates
- 28 Feb 2024to 7 Mar 2024
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Study population: Anyone working at GHSIF and has accepted to participate to the study
Who may be able to join
- Anyone working at GHSIF
Who cannot join
- Any person refusing to participate
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Evaluation of Healthcare Workers Knowledge Regarding Their Vaccination Status and Their Relationship to Vaccination at Melun Hospital
The goal of this observational study is to learn about the rate the of knowledge of own vaccination status among healthcare workers working at Groupe Hospitalier Sud Ile de France. The main question it aims to answer are : knowledge of own vaccination status is less than 50% among healthcare workers working at Groupe Hospitalier Sud Ile de France and the assessment of the relationship between healthcare workers of Groupe Hospitalier Sud Ile de France and vaccination in general.
Read the detailed description
Healthcare professionals in France are subject to a number of vaccination obligations, and following successive anti-SARS-CoV2 vaccination campaigns, these obligations are under discussion. Even healthcare professionals are reluctant to be vaccinated , particularly in view of annual vaccination rates against seasonal influenza: 22% were vaccinated against seasonal influenza in 2022, and 25.9% knew their general vaccination status.
As part of the national "European Vaccination Week" event organized by the French Ministry of Health and Prevention, we propose a questionnaire designed for hospital healthcare workers to assess their knowledge of their own vaccination status, and evaluate their attitude with vaccination.
The link to the questionnaire will be forwarded to staff e-mail addresses, and it will be administered on a one-off basis. At least 100 professionals will be surveyed. Each participant is expected to complete the questionnaire in 10 minutes, and the total duration of the research is one week.
- Conditions
- Vaccinia
- Medical subject headings
- Vaccinia
What is being measured
The primary outcome is the main question the study is designed to answer.
Evaluation of the rate of knowledge of own vaccination status
Evaluation of the rate of knowledge of own vaccination status among healthcare workers working at Groupe Hospitalier Sud Ile de France
Measured: inclusion visite
Secondary outcomes (1)
Correlation between healthcare workers and vaccination
Assessment of the relationship between healthcare workers of Groupe Hospitalier Sud Ile de France and vaccination in general.
Measured: inclusion visite
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 Oct 2024
- Study start28 Feb 2024
- Primary completion7 Mar 2024
- Study completion7 Mar 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for VacciniaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 100 participants (actual)
Sponsor and investigators
- Lead sponsor
- Groupe Hospitalier Sud Ile-de-France
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06650722
- Sponsor's protocol ID
- 2023-A00923-42
- Acronym
- STATUVAX-PRO
- Status last verified
- Sep 2024
- First submitted
- 15 Dec 2023
- Last updated
- 21 Oct 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 21 Oct 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of Healthcare Workers Knowledge Regarding Their Vaccination Status and Their Relationship to Vaccination at Melun Hospital
- ClinicalTrials.gov ID
- NCT06650722
- Acronym / sponsor ID
- STATUVAX-PRO / 2023-A00923-42
- Conditions
- Vaccinia
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 100 participants (actual)
- Lead sponsor
- Groupe Hospitalier Sud Ile-de-FranceUniversity, hospital or other
- Study start
- 28 Feb 2024 (actual)
- Primary completion
- 7 Mar 2024 (actual)
- Study completion
- 7 Mar 2024 (actual)
- First posted
- 21 Oct 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this observational study is to learn about the rate the of knowledge of own vaccination status among healthcare workers working at Groupe Hospitalier Sud Ile de France. The main question it aims to answer are : knowledge of own vaccination status is less than 50% among healthcare workers working at Groupe Hospitalier Sud Ile de France and the assessment of the relationship between healthcare workers of Groupe Hospitalier Sud Ile de France and vaccination in general.
Detailed description
Healthcare professionals in France are subject to a number of vaccination obligations, and following successive anti-SARS-CoV2 vaccination campaigns, these obligations are under discussion. Even healthcare professionals are reluctant to be vaccinated , particularly in view of annual vaccination rates against seasonal influenza: 22% were vaccinated against seasonal influenza in 2022, and 25.9% knew their general vaccination status.
As part of the national "European Vaccination Week" event organized by the French Ministry of Health and Prevention, we propose a questionnaire designed for hospital healthcare workers to assess their knowledge of their own vaccination status, and evaluate their attitude with vaccination.
The link to the questionnaire will be forwarded to staff e-mail addresses, and it will be administered on a one-off basis. At least 100 professionals will be surveyed. Each participant is expected to complete the questionnaire in 10 minutes, and the total duration of the research is one week.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Anyone working at GHSIF and has accepted to participate to the study
Key inclusion criteria (1 listed)
- Anyone working at GHSIF
Key exclusion criteria (1 listed)
- Any person refusing to participate
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Evaluation of the rate of knowledge of own vaccination status
Time frame: inclusion visite
Evaluation of the rate of knowledge of own vaccination status among healthcare workers working at Groupe Hospitalier Sud Ile de France
1 secondary outcome
Correlation between healthcare workers and vaccination
Time frame: inclusion visite
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Oct 2024.
Related trials for Vaccinia
RecruitingPhase 1
A Phase 1 Study of OTS-412 (Recombinant Oncolytic Vaccinia Virus) in Treatment-refractory Solid Tumor Patients (South Korea)
Treatment-Refractory Solid Tumors
RecruitingPhase 1
Oncolytic Virotherapy to Enhance PReoperative IMmunotherapy Efficacy in Patients With Proficient Mismatch Repair (pMMR) Rectal Cancer
Rectal Cancer Patients
Active, not recruitingPhase 1
Vaccine Therapy and Sargramostim in Treating Patients With Pancreas Cancer That Cannot Be Removed By Surgery
Locally Advanced Pancreatic Adenocarcinoma, Pancreatic Acinar Cell Carcinoma
Active, not recruitingEarly Phase 1
Evaluating the Human Immune Response to the JYNNEOS Vaccine
Vaccinia, Virus Diseases
RecruitingPhase 1/2
Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Treating Pediatric Patients With Positive Cytomegalovirus Undergoing Donor Stem Cell Transplant
Cytomegaloviral Infection, Hematopoietic Cell Transplant Recipient
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Vaccinia, run by Groupe Hospitalier Sud Ile-de-France at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 21 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Evaluation of the rate of knowledge of own vaccination status (time frame: inclusion visite). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Oct 2024.